Sort   by:  
 Page size 
UnknownTrastuzumab in Female Breast Cancer Patients With Reduced Left Ventricular Ejection Fraction.
Not available
S-EPMC6201446 | biostudies-literature
UnknownPrevalence, Severity, and Co-Occurrence of SPPADE Symptoms in 31,866 Patients With Cancer.
Not available
S-EPMC10106386 | biostudies-literature
UnknownStudy protocol for Young & Strong: a cluster randomized design to increase attention to unique issues faced by young women with newly diagnosed breast cancer.
Not available
S-EPMC4328063 | biostudies-literature
UnknownProspective evaluation of the impact of stress, anxiety, and depression on household income among young women with early breast cancer from the Young and Strong trial.
Not available
S-EPMC7541223 | biostudies-literature
UnknownUsing Electronic Health Records to Classify Cancer Site and Metastasis.
Not available
S-EPMC12176508 | biostudies-literature
UnknownPeripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progression.
Not available
S-EPMC10710020 | biostudies-literature
UnknownOlanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602).
Not available
S-EPMC10400142 | biostudies-literature
UnknownEpidemiology of diagnostic errors in pediatric emergency departments using electronic triggers.
Not available
S-EPMC11921087 | biostudies-literature
UnknownA phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer.
Not available
S-EPMC5448790 | biostudies-literature
UnknownReal-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience.
Not available
S-EPMC11936386 | biostudies-literature
Sort   by:  
 Page size